These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 3399827)
1. Evaluation of magnesium status in Crohn's disease as assessed by intracellular analysis and intravenous magnesium infusion. Sjögren A; Florén CH; Nilsson A Scand J Gastroenterol; 1988 Jun; 23(5):555-61. PubMed ID: 3399827 [TBL] [Abstract][Full Text] [Related]
2. Plasma and skeletal muscle electrolytes in patients with Crohn's disease. Nyhlin H; Dyckner T; Ek B; Wester PO J Am Coll Nutr; 1985; 4(5):531-8. PubMed ID: 4056237 [TBL] [Abstract][Full Text] [Related]
3. Magnesium and potassium status in healthy subjects as assessed by analysis of magnesium and potassium in skeletal muscle biopsies and magnesium in mononuclear cells. Sjögren A; Florén CH; Nilsson A Magnesium; 1987; 6(2):91-9. PubMed ID: 3573820 [TBL] [Abstract][Full Text] [Related]
4. Measurements of magnesium in mononuclear cells. Sjögren A; Floren CH; Nilsson A Sci Total Environ; 1985 Mar; 42(1-2):77-82. PubMed ID: 4012290 [TBL] [Abstract][Full Text] [Related]
5. Magnesium deficiency in IDDM related to level of glycosylated hemoglobin. Sjögren A; Florén CH; Nilsson A Diabetes; 1986 Apr; 35(4):459-63. PubMed ID: 3956882 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of zinc status in subjects with Crohn's disease. Sjögren A; Florén CH; Nilsson A J Am Coll Nutr; 1988 Feb; 7(1):57-60. PubMed ID: 3343476 [TBL] [Abstract][Full Text] [Related]
8. The safety of autologous and metabolically fit bone marrow mesenchymal stromal cells in medically refractory Crohn's disease - a phase 1 trial with three doses. Dhere T; Copland I; Garcia M; Chiang KY; Chinnadurai R; Prasad M; Galipeau J; Kugathasan S Aliment Pharmacol Ther; 2016 Sep; 44(5):471-81. PubMed ID: 27385373 [TBL] [Abstract][Full Text] [Related]
9. Magnesium, potassium and zinc deficiency in subjects with type II diabetes mellitus. Sjögren A; Florén CH; Nilsson A Acta Med Scand; 1988; 224(5):461-6. PubMed ID: 3202015 [TBL] [Abstract][Full Text] [Related]
10. Magnesium requirements in patients with chronic inflammatory disease receiving intravenous nutrition. Russell RI J Am Coll Nutr; 1985; 4(5):553-8. PubMed ID: 3932496 [TBL] [Abstract][Full Text] [Related]
11. The effect of intravenous magnesium therapy on serum and urine levels of potassium, calcium, and sodium in patients with ischemic heart disease, with and without acute myocardial infarction. Rasmussen HS; Cintin C; Aurup P; Breum L; McNair P Arch Intern Med; 1988 Aug; 148(8):1801-5. PubMed ID: 3041940 [TBL] [Abstract][Full Text] [Related]
12. Mg deficiency in chronic inflammatory bowel disease and requirements during intravenous nutrition. Main AN; Morgan RJ; Russell RI; Hall MJ; MacKenzie JF; Shenkin A; Fell GS JPEN J Parenter Enteral Nutr; 1981; 5(1):15-9. PubMed ID: 6785467 [TBL] [Abstract][Full Text] [Related]
13. Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease. Daig R; Andus T; Aschenbrenner E; Falk W; Schölmerich J; Gross V Gut; 1996 Feb; 38(2):216-22. PubMed ID: 8801200 [TBL] [Abstract][Full Text] [Related]
15. Reduction of circulating secretory phospholipase A2 levels by anti-tumor necrosis factor chimeric monoclonal antibody in patients with severe Crohn's disease. Relation between tumor necrosis factor and secretory phospholipase A2 in healthy humans and in active Crohn's disease. van Dullemen HM; Wolbink GJ; Wever PC; van der Poll T; Hack CE; Tytgat GN; van Deventer SJ Scand J Gastroenterol; 1998 Oct; 33(10):1094-8. PubMed ID: 9829366 [TBL] [Abstract][Full Text] [Related]